Cargando…
Yes‐associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue loss
The ability of the liver to restore its original volume following tissue loss has been associated with the Hippo‐YAP1 pathway, a key controller of organ size. Yes‐associated protein 1 (YAP1)—a growth effector usually restrained by Hippo signaling—is believed to be of particular importance; however,...
Autores principales: | Tschuor, Christoph, Kachaylo, Ekaterina, Ungethüm, Udo, Song, Zhuolun, Lehmann, Kuno, Sánchez‐Velázquez, Patricia, Linecker, Michael, Kambakamba, Patryk, Raptis, Dimitri A., Limani, Përparim, Eshmuminov, Dilmurodjon, Graf, Rolf, Columbano, Amedeo, Humar, Bostjan, Clavien, Pierre‐Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351850/ https://www.ncbi.nlm.nih.gov/pubmed/30740593 http://dx.doi.org/10.1096/fba.1023 |
Ejemplares similares
-
“A randomized, double-blind study of the effects of omega-3 fatty acids (Omegaven™) on outcome after major liver resection”
por: Linecker, Michael, et al.
Publicado: (2015) -
The value of pancreatic stone protein in predicting acute appendicitis in patients presenting at the emergency department with abdominal pain
por: Tschuor, Christoph, et al.
Publicado: (2012) -
Large-Scale Profiling of Signaling Pathways Reveals a Distinct Demarcation between Normal and Extended Liver Resection
por: Borger, Pieter, et al.
Publicado: (2020) -
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial
por: Limani, Perparim, et al.
Publicado: (2016) -
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors
por: Schneider, Marcel A., et al.
Publicado: (2021)